Abstract:Obesity, a state of excessive delivery of energy to adipose tissues, imposes a devastating health threat and cardiovascular function including the increased prevalence of hypertension, insulin resistance, diabetes mellitus, cancer, inflammation, sleep dyspnea and other cardiovascular diseases. Approximately one-third of world populations are obese while effective management remains dismal. A better understanding of the obesity and metabolic disease pathophysiology seems to be essential for the proper management of obesity and cardiometabolic diseases. Knowledge gained over the last decades for the mechanisms that underpin obesity and metabolic diseases has provided a framework for energy imbalance, oxidative stress, apoptosis and sympathetic overactivation in the pathophysiology of these metabolic anomalies. Of particular interest is the role of autophagy, a conservative homeostatic process for cellular quality control through disposal and recycling of cellular components in the maintenance of energy homeostasis and organ function. Autophagy, in particular selective autophagy such as mitophagy, manages stress by selectively ridding the cells of potentially toxic proteins, lipids and organelles. Defects in autophagy and mitophagy may contribute to the development of cardiovascular anomalies of metabolic disorders prompting the pathogenesis of obesity, insulin resistance, diabetes, and atherosclerosis. Here we will highlight the changes of autophagy in particular mitophagy receptor protein FUN-14 containing domain 1 (FUNDC1) in response to nutrient stress, and changes of FUNDC1 may alter the course of cardiovascular function in obesity and metabolic diseases. Finally, the potential of pharmacological modulation of autophagy in the management of metabolic diseases and their cardiovascular complications will be addressed.

Autophagic Regulation of Lipid Homeostasis in Cardiometabolic Syndrome

Interplay Between Lipid Metabolism and Autophagy

Regulation of Autophagy in Obesity-Induced Cardiac Dysfunction

Physiological and Pathophysiological Function of Myocardial Autophagy

Autophagy, Hyperlipidemia, and Atherosclerosis

Autophagy regulates lipid metabolism

Targeting Autophagy in the Management of Obesity and Metabolic Diseases

The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets

Lipids associated with autophagy: mechanisms and therapeutic targets

Lipids and membrane-associated proteins in autophagy

Redox Regulation of Autophagy in Dilated and Hypertrophic Cardiomyopathy

Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management

Research Progress of the Relationship between Autophagy and Lipid Deposition

Autophagy And Cardiac Diseases: Therapeutic Potential Of Natural Products

Relationship Between Autophagy and Metabolic Syndrome Characteristics in the Pathogenesis of Atherosclerosis

Relationship Between Autophagy and Lipid Metabolism

Current Status of Autophagy Enhancers in Metabolic Disorders and Other Diseases

Role of Autophagy in Inherited Metabolic and Endocrine Myopathies

Lipophagy and Liver Disease: New Perspectives to Better Understanding and Therapy.

Therapeutic regulation of autophagy in hepatic metabolism

The Role of Autophagy in Cardiac Hypertrophy.